Images List Premium Download Classic

Cardiac Arrhythmia

Cardiac Arrhythmia-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Oxytocin improves treatment of obstructive sleep apnea
May 25, 2017 - N°20170143790

The present disclosure provides methods for treating obstructive sleep apnea (osa) and osa induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: osa or osa induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in osa patients by administering oxytocin.
Energy delivery systems and uses thereof
Neuwave Medical, Inc.
April 27, 2017 - N°20170112571

Provided herein are devices, systems, and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e. G., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, devices, systems, and methods are provided for delivering energy to difficult to access tissue regions (e. G. Central ...
Energy delivery systems and uses thereof
Neuwave Medical, Inc.
April 20, 2017 - N°20170105799

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e. G., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e. G., a tumor) ...
Cardiac Arrhythmia Patent Pack
Download + patent application PDFs
Cardiac Arrhythmia Patent Applications
Download + Cardiac Arrhythmia-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cardiac Arrhythmia-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and apparatus for detecting cardiac arrhythmia and recording medium using the method
Htc Corporation
March 16, 2017 - N°20170071482

A method and an apparatus for detecting cardiac arrhythmia and a recording medium using the method are provided. In the method, physiological signals of a human comprising a sequence of heart pulses are acquired, and an average of heartbeat intervals between pairs of consecutive heart pulses in the sequence of heart pulses is calculated. Each pair of consecutive heartbeat intervals ...
Ablation targeting nerves in or near the inferior vena cava and/or abdominal aorta for ...
Biosense Webster (israel), Ltd.
March 09, 2017 - N°20170065338

A method for the treatment of a patient for the purpose of lowering blood pressure and/or treating other medical conditions such as cardiac arrhythmias. A catheter having an ablation element is placed inside the body of a patient and is directed to a targeted location either on in the abdominal aorta where the right or left renal arteries branch ...
Apparatus and method for identifying atrial arrhythmia by far-field sensing
Cameron Health, Inc.
March 02, 2017 - N°20170056681

In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient. The sensed cardiac signal information is then amplified and filtered. Parameters such as rate, qrs pulse width, cardiac qrs slew rate, amplitude and stability measures of these parameters from the filtered cardiac ...
Cardiac Arrhythmia Patent Pack
Download + patent application PDFs
Cardiac Arrhythmia Patent Applications
Download + Cardiac Arrhythmia-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cardiac Arrhythmia-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Systems and methods for leadless pacing and shock therapy
Medtronic, Inc.
February 16, 2017 - N°20170043174

Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (sicd) and a leadless pacing device (lpd) are described. For example, the sicd may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the ...
Novel cyp-eicosanoid derivatives
Board Of Regents, The University Of Texas System
January 12, 2017 - N°20170008918

The present invention relates to compounds according to general formula (i) which are analogues of epoxymetabolites produced by cytochrome p450 (cyp) enzymes from omega-3 (n-3) polyunsaturated fatty acids (pufas). The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for c the treatment or prevention of conditions ...
Short acting phenylalkylamine calcium channel blockers and uses thereof
Milestone Pharmaceuticals Inc.
December 29, 2016 - N°20160374982

The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow. The invention also relates to pharmaceutical compositions formulated ...
Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
Milestone Pharmaceuticals Inc.
December 22, 2016 - N°20160367599

Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (prp) composition are provided. Any type of arrhythmia may be treated using the prp composition. The prp composition may comprise prp developed using blood collected from a patient suffering the cardiac arrhythmia. The prp composition may be buffered to a physiological ph and may include one or ...
Energy delivery systems and uses thereof
Neuwave Medical, Inc.
December 22, 2016 - N°20160367318

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e. G., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e. G., a tumor) ...
Irrigated ablation catheter
Osypka Ag
December 22, 2016 - N°20160367313

The present invention relates to catheters in general and more particularly to improvements in so-called “irrigated ablation catheter” that may be used in mapping and ablation procedures of tissue, preferably heart tissue in the treatment of cardiac arrhythmia. The present invention is directed irrigated ablation catheter comprising an elongated catheter shaft (4), a deflectable section (3) distal to ...
Method of reducing the occurrence of arrhythmias via photobiomodulation and apparatus for same
St. Jude Medical, Atrial Fibrillation Division, Inc.
December 15, 2016 - N°20160361562

In response to local or systemic inflammation in a patient, photobiomodulation therapy is applied to a cardiac location to reduce the risk and/or occurrence of cardiac arrhythmia. Once inflammation is identified, photobiomodulation therapy can be applied in any suitable fashion (e. G., via a catheter- or transesophageal probe-mounted photoemitter, via an externally-applied photoemitter, or via photoemitter incorporated into an ...
Cardiac Arrhythmia Patent Pack
Download + patent application PDFs
Cardiac Arrhythmia Patent Applications
Download + Cardiac Arrhythmia-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cardiac Arrhythmia-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Small loop ablation catheter
St. Jude Medical, Atrial Fibrillation Division, Inc.
November 03, 2016 - N°20160317223

A catheter system for creating lesions for the treatment of cardiac arrhythmias is disclosed that includes a catheter having a distal ablation segment that has an electrode array comprising a plurality of spaced ablation and recording electrode devices arranged in a tight loop configuration that is used to create a series of overlapping loop-shaped ablation footprints to produce a continuous ...
Compounds for treatment of cardiac arrhythmias
Baylor College Of Medicine
October 27, 2016 - N°20160311760

Compounds and methods thereof for reducing cardiac arrhythmia are described. In particular, compounds generated by adding chemical groups that enhance the electron donor properties of ryr inhibitors may increase inhibitor potency and thus allow for new more potent anti-arrhythmic drugs. One advantage of the compounds and methods described is a potential for drugs with enhanced electron donor properties that may ...
Methods for calibrating the administration of vanoxerine for terminating acute episodes of cardiac arrhythmia, restoring ...
Laguna Pharmaceuticals , Inc.
October 20, 2016 - N°20160305924

Disclosed embodiments are related to methods for administering compositions of vanoxerine (gbr 12909) to patients by calibrating an effective dose for treatment of cardiac arrhythmias.
Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute ...
Laguna Pharmaceuticals, Inc.
October 20, 2016 - N°20160304477

Disclosed embodiments are related to pharmaceutical compositions comprising novel piperazine compounds and methods of administration of the same to a patient for termination acute episodes of cardiac arrhythmias, maintaining normal sinus rhythm, restoring normal sinus rhythm, and preventing recurrence of cardiac arrhythmia.
Devices and methods for treating cardiovascular and metabolic disease
Laguna Pharmaceuticals, Inc.
October 20, 2016 - N°20160303381

Some embodiments of devices and methods described herein may, among other uses, favorably cause the activation and/or deactivation vascular baroreceptors in order to achieve a desired impact on physiological condition, including but not limited to baroreflex-regulated conditions, hypertension, hypotension, nervous system disorders, metabolic disorders, cardiovascular disease, heart failure, cardiac arrhythmia, renal disease, respiratory disease, diabetes, and insulin resistance. The ...
Pharmaceutical compositions containing vanoxerine and p450 inhibitors and methods of terminating acute episodes of cardiac ...
Laguna Pharmaceuticals, Inc.
October 20, 2016 - N°20160303114

Compositions comprising vanoxerine (gbr 12909) and a p450 inhibitor, including compositions of vanoxerine and one or more p450 inhibitors, processes for their preparation thereof, and methods of using the same for treatment of cardiac arrhythmias.
Methods of self-administration of vanoxerine for terminating acute episodes of cardiac arrhythmia in mammals
Laguna Pharmaceuticals ,inc.
October 20, 2016 - N°20160303113

Disclosed embodiments are related to methods of administration of vanoxerine wherein a patient, previously and successfully treated for cardiac arrhythmia with vanoxerine is prescribed a further dose for self-administration of a further dose of vanoxerine for treatment of a subsequent occurrence of cardiac arrhythmia.
Methods of remote monitoring of self-administration of vanoxerine for terminating acute episodes of cardiac arrhythmia ...
Laguna Pharmaceuticals, Inc.
October 20, 2016 - N°20160303112

Disclosed embodiments are related to methods of remotely monitoring a patient being treated for cardiac arrhythmia wherein a patient, previously and successfully treated for cardiac arrhythmia with vanoxerine is prescribed a further dose for self-administration of a further dose of vanoxerine for treatment of a subsequent occurrence of cardiac arrhythmia and instructed to remotely monitor said subsequent occurrence of cardiac ...
Loading